4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-002697
CEO bought 20,416 shares at an average $0.73 ($14,909)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2025-03-20 | Purchase | +5,416 | $0.73 | $3,950 | 1,309,296 | D |
| Vaddi Krishna CEO | 2025-03-21 | Purchase | +15,000 | $0.73 | $10,959 | 1,324,296 | D |
| Open-market purchases · 20,416 sh · avg $0.73 · $14,909 | |||||||
Loading xslF345X05/primarydocument.xml…